Thibault Boutherin
Stock Analyst at Morgan Stanley
(n/a)
# 4,964
Out of 5,139 analysts
4
Total ratings
n/a
Success rate
-24.5%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALVO Alvotech | Upgrades: Overweight | $14 | $4.92 | +184.55% | 2 | Oct 14, 2025 | |
| NVO Novo Nordisk | Downgrades: Underweight | $59 → $47 | $62.33 | -24.59% | 1 | Sep 29, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Equal-Weight | $10 | $31.76 | -68.51% | 1 | May 25, 2023 |
Alvotech
Oct 14, 2025
Upgrades: Overweight
Price Target: $14
Current: $4.92
Upside: +184.55%
Novo Nordisk
Sep 29, 2025
Downgrades: Underweight
Price Target: $59 → $47
Current: $62.33
Upside: -24.59%
Teva Pharmaceutical Industries
May 25, 2023
Initiates: Equal-Weight
Price Target: $10
Current: $31.76
Upside: -68.51%